Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A28011 | 16733858 | World J Gastroenterol | Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. | 2006 | Details |
| A28012 | 16732016 | Diabetes Care | Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. | 2006 | Details |
| A28015 | 16712671 | Clin Endocrinol (Oxf) | Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A28019 | 16706822 | J Gastroenterol Hepatol | Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. | 2006 | Details |
| A28023 | 16697719 | Gastroenterology | Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. | 2006 | Details |
| A28027 | 16689200 | J Chin Med Assoc | Nonalcoholic fatty liver disease manifesting esophageal variceal bleeding. | 2006 | Details |
| A28030 | 16680031 | Curr Opin Lipidol | New insights in the pathogenesis of non-alcoholic fatty liver disease. | 2006 | Details |
| A28037 | 16630771 | Clin Gastroenterol Hepatol | A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. | 2006 | Details |
| A28039 | 16624332 | Life Sci | High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. | 2006 | Details |
| A28045 | 16609997 | World J Gastroenterol | Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. | 2006 | Details |
| A28047 | 16603025 | Clin Sci (Lond) | Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. | 2006 | Details |
| A28051 | 28286458 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. | 2006 | Details |
| A28052 | 19858588 | Saudi J Gastroenterol | The role of leptin in non-alcoholic fatty liver disease. | 2009 | Details |
| A28055 | 16557185 | Minerva Gastroenterol Dietol | Non-alcoholic fatty liver disease and hepatitis C infection. | 2006 | Details |
| A28057 | 16545157 | Obes Surg | Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. | 2006 | Details |
| A28060 | 16540769 | J Clin Gastroenterol | Therapy of NAFLD: antioxidants and cytoprotective agents. | 2006 | Details |
| A28061 | 16540768 | J Clin Gastroenterol | The epidemiology of nonalcoholic fatty liver disease in adults. | 2006 | Details |
| A28063 | 16540765 | J Clin Gastroenterol | Diagnostic evaluation of nonalcoholic fatty liver disease. | 2006 | Details |
| A28067 | 16534679 | Dig Dis Sci | Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment? | 2006 | Details |
| A28068 | 16531961 | Ann Hepatol | Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. | 2006 | Details |
| A28071 | 16521351 | Clin Med (Lond) | Non-alcoholic fatty liver disease: current concepts and management strategies. | 2007 | Details |
| A28072 | 16516152 | Biochem Biophys Res Commun | Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. | 2006 | Details |
| A28074 | 16506276 | Diabetes Metab Res Rev | Diabetes in chronic liver disease: from old concepts to new evidence. | 2006 | Details |
| A28076 | 16503961 | BMC Gastroenterol | Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A28081 | 16496750 | Recenti Prog Med | [Steatosis and hepatitis C]. | 2005 | Details |
| A28083 | 16491048 | Minerva Gastroenterol Dietol | The pathology of nonalcoholic steatohepatitis. | 2002 | Details |
| A28085 | 16487446 | Clin Endocrinol (Oxf) | Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. | 2006 | Details |
| A28088 | 16469684 | Clin Gastroenterol Hepatol | Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. | 2006 | Details |
| A28092 | 16454845 | Am J Gastroenterol | Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. | 2006 | Details |
| A28093 | 16452829 | Keio J Med | Fat paradox in liver disease. | 2005 | Details |
| A28094 | 16448452 | Liver Int | Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A28095 | 16447287 | Hepatology | Nonalcoholic fatty liver disease: from steatosis to cirrhosis. | 2006 | Details |
| A28096 | 16439872 | AIDS | Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients. | 2006 | Details |
| A28104 | 16416204 | Dig Dis Sci | Nonalcoholic fatty liver disease treated by gastroplasty. | 2006 | Details |
| A28108 | 16398679 | Pathol Int | Hepatocellular carcinoma with silent and cirrhotic non-alcoholic steatohepatitis, accompanying ectopic liver tissue attached to gallbladder. | 2006 | Details |
| A28112 | 16393299 | Aliment Pharmacol Ther | Review article: Drug therapy for non-alcoholic fatty liver disease. | 2006 | Details |
| A28115 | 16385233 | Alcohol Clin Exp Res | Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease. | 2005 | Details |
| A28116 | 16380770 | Saudi Med J | Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis. | 2005 | Details |
| A28118 | 16376797 | Clin Liver Dis | Nonalcoholic fatty liver disease in children. | 2006 | Details |
| A28129 | 16340230 | Med Princ Pract | Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. | 2006 | Details |
| A28134 | 16293559 | Scand J Gastroenterol | Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. | 2005 | Details |
| A28140 | 16275057 | Hepatol Res | Clinical and pathological features of non-alcoholic steatohepatitis. | 2005 | Details |
| A28143 | 16270394 | World J Gastroenterol | Association between thrombotic risk factors and extent of fibrosis in patients with non-alcoholic fatty liver diseases. | 2005 | Details |
| A28144 | 16268963 | Aliment Pharmacol Ther | Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones. | 2005 | Details |
| A28145 | 16265156 | Nat Clin Pract Gastroenterol Hepatol | Treatment strategies in nonalcoholic fatty liver disease. | 2005 | Details |
| A28146 | 16265100 | Nat Clin Pract Gastroenterol Hepatol | Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. | 2005 | Details |
| A28149 | 16259893 | Obes Surg | The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery. | 2005 | Details |
| A28150 | 16259794 | Ann Clin Biochem | Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? | 2005 | Details |
| A28154 | 16252194 | Turk J Gastroenterol | Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. | 2005 | Details |
| A28155 | 16252180 | Turk J Gastroenterol | Apoptosis and fibrosis in non-alcoholic fatty liver disease. | 2005 | Details |
| A28165 | 16231594 | Eur Rev Med Pharmacol Sci | The treatment of NAFLD. | 2006 | Details |
| A28167 | 16231591 | Eur Rev Med Pharmacol Sci | Steatosis and portal hypertension. | 2006 | Details |
| A28168 | 16231589 | Eur Rev Med Pharmacol Sci | The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. | 2006 | Details |
| A28169 | 16231588 | Eur Rev Med Pharmacol Sci | Hepatic steatosis and vascular disease. | 2006 | Details |
| A28174 | 16225478 | Aliment Pharmacol Ther | Review article: role of oxidative stress in the progression of non-alcoholic steatosis. | 2005 | Details |
| A28177 | 16225473 | Aliment Pharmacol Ther | Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications. | 2005 | Details |
| A28178 | 16225472 | Aliment Pharmacol Ther | Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis. | 2005 | Details |
| A28181 | 16225467 | Aliment Pharmacol Ther | Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study. | 2005 | Details |
| A28182 | 16214395 | Hepatol Res | Pathology of nonalcoholic steatohepatitis. | 2005 | Details |
| A28184 | 16212004 | Rev Med Suisse | [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms]. | 2005 | Details |
| A28187 | 16203174 | Hepatol Res | The characteristics and natural history of Japanese patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A28189 | 16201116 | Hepatogastroenterology | Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. | 2005 | Details |
| A28190 | 16198624 | Hepatol Res | Lessons from animal models of NASH. | 2005 | Details |
| A28191 | 16198623 | Hepatol Res | The role of leptin in progression of non-alcoholic fatty liver disease. | 2005 | Details |
| A28192 | 16198621 | Hepatol Res | Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. | 2005 | Details |
| A28193 | 16198620 | Hepatol Res | Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH). | 2005 | Details |
| A28195 | 16192822 | Ann Surg | Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. | 2005 | Details |
| A28203 | 16150132 | J Hum Nutr Diet | Body mass index and waist circumference in non-alcoholic fatty liver disease. | 2005 | Details |
| A28208 | 16139921 | J Hepatol | Adiponectin and its receptors in patients with chronic hepatitis C. | 2005 | Details |
| A28212 | 16118460 | Methods Mol Med | Genetic studies to identify hepatic fibrosis genes and SNPs in human populations. | 2005 | Details |
| A28214 | 16116629 | Hepatology | Histopathology of pediatric nonalcoholic fatty liver disease. | 2005 | Details |
| A28221 | 16092984 | Zhonghua Gan Zang Bing Za Zhi | [A study of the changes of hepatic gene expression in the process of nonalcoholic fatty liver disease development using U230A oligonucleotide microarray]. | 2005 | Details |
| A28223 | 16076987 | Obes Res | Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. | 2005 | Details |
| A28227 | 16037946 | Hepatology | Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. | 2005 | Details |
| A28233 | 16003133 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum. | 2005 | Details |
| A28235 | 15998429 | Liver Int | Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. | 2005 | Details |
| A28238 | 15990709 | Minerva Gastroenterol Dietol | [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study]. | 2005 | Details |
| A28251 | 15951547 | Gut | Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. | 2005 | Details |
| A28253 | 15946458 | Obes Surg | Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. | 2005 | Details |
| A28255 | 15946428 | Obes Surg | Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies. | 2005 | Details |
| A28257 | 15940625 | Gastroenterology | Sampling variability of liver biopsy in nonalcoholic fatty liver disease. | 2005 | Details |
| A28262 | 15918975 | Zhonghua Gan Zang Bing Za Zhi | [Expression of uncoupling protein 2 and its relationship to the content of adenosine triphosphate in the nonalcoholic fatty livers of rats fed a high-fat diet]. | 2005 | Details |
| A28263 | 15918331 | Antivir Ther | Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. | 2005 | Details |
| A28264 | 15917956 | Braz J Med Biol Res | Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. | 2005 | Details |
| A28265 | 15915461 | Hepatology | Design and validation of a histological scoring system for nonalcoholic fatty liver disease. | 2005 | Details |
| A28272 | 15859390 | Ann Ital Med Int | [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?]. | 2005 | Details |
| A28273 | 15842582 | Am J Gastroenterol | A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. | 2005 | Details |
| A28278 | 15826462 | Obes Surg | Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. | 2005 | Details |
| A28279 | 15824194 | Hypertension | Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction. | 2005 | Details |
| A28281 | 15822044 | Clin Gastroenterol Hepatol | Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A28285 | 15797948 | J Clin Endocrinol Metab | Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. | 2005 | Details |
| A28286 | 15788885 | Korean J Hepatol | [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease]. | 2005 | Details |
| A28287 | 15784031 | Am J Gastroenterol | Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. | 2005 | Details |
| A28289 | 15780053 | Liver Int | Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. | 2005 | Details |
| A28291 | 15769638 | Front Biosci | Pathological features of NASH. | 2005 | Details |
| A28293 | 15763346 | J Hepatol | Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. | 2005 | Details |
| A28294 | 15763228 | Clin Liver Dis | Morphology of alcoholic liver disease. | 2005 | Details |
| A28296 | 15759791 | Rev Gastroenterol Mex | [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis]. | 2005 | Details |
| A28297 | 15754775 | Chang Gung Med J | An adipocentric view of liver fibrosis and cirrhosis. | 2004 | Details |
| A28298 | 15754745 | Gac Med Mex | [Prevalence of non-alcoholic esteatohepatitis in adults with metabolic syndrome in Oaxaca]. | 2005 | Details |